(Q40408992)

20 September 2017

title

New prospects for lipid-lowering drugs (English)

1 reference

20 September 2017

Thompson GR

1

1 reference

20 September 2017

Naoumova RP

series ordinal

2

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Expert Opinion on Investigational Drugs

20 September 2017

published in

1 reference

20 September 2017

volume

7

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

715-727

1 reference

Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Cholesteryl ester transfer protein: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.5.715

21 January 2018

Identifiers

DOI

10.1517/13543784.7.5.715

1 reference

20 September 2017

1 reference